SB-265610
SB-265610 (GSK-CXCR2) is a potent, nonpeptide allosteric antagonist of the CXCR2 receptor. It effectively inhibits CINC-1-induced calcium mobilization and neutrophil chemotaxis with IC50 values of 3.7 nM and 70 nM, respectively. This compound is a valuable research tool for studying CXCR2-mediated inflammatory responses in both cellular and animal models of disease.
Product Specifications
CAS Number
211096-49-0
Product Name Alternative
Inhibitor, nonpeptide, inhibit, inflammation, neutrophil, GSK-CXCR2, healing, Delay, CXCR, CXCR2, CXC chemokine receptors, wound, recruitment, SB265610, SB-265610, SB 265610
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
97.67% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.6 mM) ; DMSO:66 mg/mL (184.79 mM)
Smiles
Brc1ccccc1NC (=O) Nc1ccc (C#N) c2nn[nH]c12
Molecular Formula
C14H9BrN6O
Molecular Weight
357.16
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880412-100 1x 100 µL
CD30 (CD30/412), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details